Skip to Content

Bortezomib medac 3.5 mg powder for solution for injection

Licence status
Authorised: 18/05/2018
Active substances
Bortezomib
Dosage Form
Powder for solution for injection
Licence number
PA0623/018/001
Licence holder
medac Gesellschaft für klinische Spezialpräparate mbH

Licence information

ATC code
L01XX Other antineoplastic agents, L01XX32 bortezomib
Route of supply
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
18/05/2018

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie